Boehringer Ingelheim Animal Health’s 2020 BVDzero case study award scheme is now open for applications from veterinary practitioners, those working in diagnostics, research, animal science and animal health and welfare throughout the UK and Ireland.
The top 10 clinical case studies entered will share a €15,000 prize and will be invited to the award ceremony in May at Boehringer’s headquarters in Germany. Winners will be selected by the BVDzero committee, which is made up of a panel of external, renowned experts in bovine health.
Applications can be submitted through the BVDzero websiteand the closing date for entries is 20 March 2020. The list of the 2018 winners which also includes the awarded amounts is available online.
Through the BVDzero Awards, Boehringer Ingelheim aims to encourage the search for both clinical and subclinical cases of BVD (Bovine viral diarrhoea) in cattle herds. The company believes that it will help increase the awareness of BVD and, as a result, help reduce its prevalence.
“Bovine viral diarrhoea is one of the most common diseases in cattle, causing harm to the affected animals and huge economic damage to the livestock industry. We aim to challenge the status quo and bring a paradigm shift in the control of BVD globally,” explained Steve Williams, Head of Global Ruminants/Cattle Strategic Business Unit at Boehringer Ingelheim.
